2) Balance sheet computations. (Balance Sheet) Presented below is the trial balance of Malady Corporation at December 31, 2020. Debit Credit Cash 295,000 Sales Revenue $12,150,000 Debt Investments (trading) (at cost, $218,000) 230,000 Cost of Goods Sold 7,200,000 Debt Investments (long-term) 448,000 Equity Investments (long-term) 416,000 Notes Payable (short-term) 135,000 Accounts Payable 682,000 Selling Expenses 3,000,000 Investment Revenue 95,000 Land 390,000 Buildings 1,560,000 Dividends Payable 204,000 Accrued Liabilities 144,000 Accounts Receivable 652,000 Accumulated Depreciation-Buildings 228,000 Allowance for Doubtful Accounts 38,000 Administrative Expenses 1,350,000 Interest Expense 317,000 Inventory 895,000 sted.cuny.edu/bbcswebdav/pid-61353380-dt-conte03_E134_1219_1/Fall%202021%20BU103%20Exam%201%20 Gain Notes Payable (long-term) Equipment Bonds Payable Accumulated Depreciation-Equipment Franchises Common Stock ($5 par) Treasury Stock Patents Retained Earnings Paid-in Capital in Excess of Par Totals 120,000 1,350,000 900,000 1,500,000 90,000 240,000 1,500,000 287,000 293,000 117,000 120.000 $18.473.000 $18.473.000 Instructions Compute each of the following: Total current assets 2. Total property, plant, and equipment 3. Total assets 4. Total liabilities 5. Total stockholders' equity